BiondVax
BVXV
#10423
Rank
S$6.38 M
Marketcap
S$1.75
Share price
0.74%
Change (1 day)
-40.69%
Change (1 year)

Revenue for BiondVax (BVXV)

Revenue in 2023 (TTM): N/A

In 2021 the company made a revenue of N/A a decrease over the revenue in the year 2020 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BiondVax from 2014 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA